Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: A case-control matched analysis.
Lingling YangTianzhou WuJiang LiJiaojiao XinDongyan ShiJing JiangXi LiangYingyan LuHeng YaoHuafen ZhangSuwan SunTan LiHozeifa Mohamed Hassan MohamedJiaqi LiKeke RenBeibei GuoXingping ZhouJiaxian ChenShaorui HaoJiajia ChenShaojie XinChen PanTao HanYongping ChenShumei LinZhongping DuanXiaowei XuJianrong HuangXin ChenLan-Juan LiJun Linull nullPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)
ALSS treatment can improve short-term survival and is associated with a significantly lower risk of short-term mortality in patients with HBV-ACLF, especially ACLF-2.